Rein Therapeutics Inc. (RNTX) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$383
Total Return
-96.17%
CAGR
-47.92%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -2.18% |
| Median | -6.13% |
| Best | +239.86% |
| Worst | -54.42% |
| % of Windows Positive | 40.1% |
1-Year (252 Trading Days)
| Average | -13.96% |
| Median | -51.86% |
| Best | +409.95% |
| Worst | -90.65% |
| % of Windows Positive | 25.4% |
3-Year (756 Trading Days)
| Average | -65.53% |
| Median | -75.00% |
| Best | +37.99% |
| Worst | -92.36% |
| % of Windows Positive | 3.4% |
Risk Metrics
| Maximum Drawdown | -96.54% |
| Average Drawdown | -81.66% |
| Drawdown Duration | 1239 Trading Days (Unrecovered) |
| Sortino Ratio | -0.16 |
| Calmar Ratio | -0.50 |
| CVaR (5%) | -12.95% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -12.07% (-26.29% ann.) | $1206.70 | $0.00 | $0.00 | $0.00 |
| 2025 | -49.57% | $4956.80 | $0.00 | $0.00 | $0.00 |
| 2024 | -24.57% | $2456.79 | $0.00 | $0.00 | $0.00 |
| 2023 | +28.65% | +$2865.48 | $0.00 | $0.00 | $0.00 |
| 2022 | -78.95% | $7895.26 | $0.00 | $0.00 | $0.00 |
| 2021 | -45.86% | $4586.48 | $0.00 | $0.00 | $0.00 |
| 2020 | +81.50% | +$8149.88 | $0.00 | $0.00 | $0.00 |
| 2019 | -31.79% | $3178.53 | $0.00 | $0.00 | $0.00 |
| 2018 | -92.03% | $9203.03 | $0.00 | $0.00 | $0.00 |
| 2017 partial | -2.41% (-4.75% ann.) | $240.74 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 29, 2017 – February 19, 2020 | -93.52% | -64.50% | $9351.85 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -54.93% | -99.99% | $5492.92 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +228.49% | +577.79% | +$22848.80 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -41.68% | -40.05% | $4168.20 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -70.50% | -72.65% | $7050.24 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -10.00% | -5.53% | $1000.34 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -61.51% | -42.87% | $6151.28 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.